A Novel Retinal Ganglion Cell Promoter for Utility in AAV Vectors

Significant advances in gene therapy have enabled exploration of therapies for inherited retinal disorders, many of which are in preclinical development or clinical evaluation. Gene therapy for retinal conditions has led the way in this growing field. The loss of retinal ganglion cells (RGCs) is a h...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanlon, Killian S., Chadderton, Naomi, Palfi, Arpad, Blanco Fernandez, Alfonso, Humphries, Peter, Kenna, Paul F., Millington-Ward, Sophia, Farrar, G. Jane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5613148/
https://www.ncbi.nlm.nih.gov/pubmed/28983234
http://dx.doi.org/10.3389/fnins.2017.00521

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5613148/
https://www.ncbi.nlm.nih.gov/pubmed/28983234
http://dx.doi.org/10.3389/fnins.2017.00521

Ejemplares similares